Novartis Ag (NVS)

Novartis (NVS) Stock Price & Analysis


NVS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$72.08 - $105.56
Previous Close$100.65
Average Volume (3M)2.24M
Market Cap
Enterprise Value$202.01B
Total Cash (Recent Filing)$143.00M
Total Debt (Recent Filing)$1.79B
Price to Earnings (P/E)30.8
Jul 18, 2023
2.25 (2.25%)
Share Statistics
EPS (TTM)3.27
Shares Outstanding2,280,000,000
10 Day Avg. Volume2,648,663
30 Day Avg. Volume2,241,502
Standard Deviation0.06
Financial Highlights & Ratios
Price to Book (P/B)-3.72
Price to Sales (P/S)4.44
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.21
Enterprise Value/Gross Profit5.76
Enterprise Value/Ebitda16.19
Price Target Upside18.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Novartis Ag’s price range in the past 12 months?
Novartis Ag lowest stock price was $72.08 and its highest was $105.56 in the past 12 months.
    What is Novartis Ag’s market cap?
    Currently, no data Available
    When is Novartis Ag’s upcoming earnings report date?
    Novartis Ag’s upcoming earnings report date is Jul 18, 2023 which is in 39 days.
      How were Novartis Ag’s earnings last quarter?
      Novartis Ag released its earnings results on Apr 25, 2023. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.532 by $0.178.
        Is Novartis Ag overvalued?
        According to Wall Street analysts Novartis Ag’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Novartis Ag pay dividends?
          Novartis Ag pays a Annually dividend of $2.25 which represents an annual dividend yield of 2.31%. See more information on Novartis Ag dividends here
            What is Novartis Ag’s EPS estimate?
            Novartis Ag’s EPS estimate is $1.69.
              How many shares outstanding does Novartis Ag have?
              Novartis Ag has 2,277,477,800 shares outstanding.
                What happened to Novartis Ag’s price movement after its last earnings report?
                Novartis Ag reported an EPS of $1.71 in its last earnings report, beating expectations of $1.532. Following the earnings report the stock price went up 3.43%.
                  Which hedge fund is a major shareholder of Novartis Ag?
                  Among the largest hedge funds holding Novartis Ag’s share is Dodge & Cox. It holds Novartis Ag’s shares valued at 2B.


                    Novartis Stock Smart Score

                    The Novartis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Novartis Ag

                    Novartis AG develops, manufactures and sells healthcare products. Its two reporting segments are: Innovative Medicines and Sandoz. The Innovative Medicines business develops and sells patented prescription medicines and is made up of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.


                    Top 5 ETFs holding NVS

                    Market Value
                    Smart Score
                    Healthcare LdrIncmUn
                    Harvest Healthcare Leaders Income ETF Trust Units B Unhedged
                    Invesco International Dividend Achievers ETF
                    VanEck Pharmaceutical ETF
                    Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged
                    Up to five ETFs with an Outperform Smart Score that hold NVS. The ETFs are listed according to market value of NVS within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Merck & Company
                    Bristol Myers

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis